Health Services Research and Pharmacy Practice

HSRPP Manchester 2010

“PHARMACY PRACTICE RESEARCH: COMING OF AGE?”

DAY 1:   Monday 12th April 2010

9.30    Registration and coffee Registration Desk, 1st Floor, Stopford Building 10.30   Welcome and Introduction to the Conference Lecture Theatre 2, 1st Floor

Ndeshi Salema, winner of the best oral communication at the 16th Health Services Research and Pharmacy Practice Conference, Manchester, April 2010" (£75 book token).

 

10.45   Key Note Plenary Presentation 1:
Evidence based management? Commissioning research to inform decision making by NHS managers. Professor Kieran Walshe

There is a growing expectation that decisions about the organisation, management and delivery of health services should be based on good evidence about what works - and that NHS managers and leaders should be able to access, appraise and apply research evidence in their work. This presentation will explore the way the NIHR service delivery and organisation (SDO) programme has set about both research production and knowledge mobilisation, and will discuss its funding streams and future research priorities and their implications for pharmacy practice research.

Kieran Walshe is Professor of Health Policy and Management at Manchester Business School, Director of the Institute of Health Sciences, and the NIHR SDO programme Director.

 

11.30   Key Note Plenary Presentation 2
Advancing implementation and health services research - policy and practice. Professor Anne Rogers

Implementation research – the study of promoting the systematic uptake of evidence based research into routine practice as a means of improving the quality of health care - is the focus of a number of programmes run from within the National Institute of Health Research (e.g, Research for Patient Benefit). This presentation will focus on how, within the broader context of health services, implementation research has sought to move beyond informing to changing practice in the NHS and beyond. Using examples, (mainly in the area of chronic illness management and self care), where principally qualitative methods have been used I will explore the way in which progress has been made in understanding and promoting a patient focused agenda with regard to implementation. The relevance of directing implementation research on patient and professional health care interactions within and beyond the boundaries of health care to home and community will be explored. Finally, the critical questions and future health care priorities related to the NHS that pharmacy could play into will be explored.

Anne Rogers is Professor of the Sociology of Health Care, at the National Primary Care Research and Development Centre, the University of Manchester, and committee member on The Research for Patient Benefit (RfPB) programme.

 

12.15   Lunch - Common Room, 1st Floor

1.15 to 3.00pm    Oral papers: parallel sessions 1

1A	METHODS – CHAIR: CHRISTINE BOND. Lecture Theatre 5 - 2nd Floor Stopford Building
1	Discrete choice experiments (DCEs) to inform pharmacy policy: going beyond quality-adjusted life years (QALYs). M. Tinelli, M. Ryan and C. Bond
2	Recruitment of individuals with enduring mental health conditions for health services research. H.E. Dawson, J. Sutton and D.A. Taylor
3	Using social network analysis to study integration between general practitioners and community pharmacists: a novel application. F. Bradley, D.M. Ashcroft and N. Crossley
1B	PRESCRIBING – CHAIR: DAVID WRIGHT - Lecture Theatre 2 - 1st floor, Stoford Building
1	Primary care and hospital doctors’ experiences of a shared electronic patient medical record system: transfer of information about patients’ drug therapies. Ljungberg, C., Kettis Lindblad, Å., Mörlin, C., Schwan, Å., Tully, M. P.
2	Understanding the factors influencing the prescribing decisions of nurse and pharmacist prescribers. C. Maddox, M. Tully and J. Hall
3	Appropriate prescribing in long-term care facilities. C. Ryan, D. O’Mahony, J. Kennedy, P. Weedle and S. Byrne
4	Factors influencing appropriate prescription of venous thromboembolism prophylaxis for medical patients. A.J. Basey and S. Pradham
1C	THE PHARMACY PROFESSION 1 - CHAIR: BETH ALLEN. Lecture theatre 4 - 2nd floor, Stopford Building
1	Work-life balance by pharmacy type: does size matter? E.M. Seston and K. Hassell
2	Are pharmacists in Wales undertaking practice research? S.A. Coulman, W.H. Chong and D.N. John
3	Methodology for assessing the appropriateness of continuing professional development for pharmacy professionals’ revalidation. P. Donyai, P.M. Denicolo, R.Z. Herbert and A. Alexander
4	Experiences of European-trained pharmacists in Great Britain. Z. Ziaei, K. Hassell and EI. Schafheutle
	PHD FORUM - CHAIR: DAI JOHN - Postgraduate Training Room, 1st Floor, Stopford Building
1	Evaluation of Enhanced Service in England. M Ali, Z Aslanpour, S Dhillon
2	Quality assurance of innovative services in community pharmacy - The role of Point of Care Testing (POCT). Oduniyi, O.
3	Evaluation of pharmacist-led weight management clinics. Sriwisit S.

3.00  Coffee break – Common Room, 1st Floor, Stopford Building

3.30 - 4.45pm - Oral papers  

2A	YOUNG PEOPLE - CHAIR: JAMES DESBOROUGH - Lecture Theatre 4, 2nd Floor
1	Use of over-the-counter weight-loss products among students. J. Krska, A.M. Andronicou, A. Hackett and J. Richards
2	Medicine-taking interventions in children and young people: one size fits all, one size fits none. N.A. Lafond, R. Churchill, H. Pandya, A. Smyth, J. Williams, R.A. Elliott
3	Click, capture, converse: using photography to elicit adolescents’ views regarding asthma management. N.M. Salema, R.A. Elliott and C. Glazebrook
2B	THE PHARMACY PROFESSION 2 - CHAIR: SIAN WILLIAMS - Lecture Theatre 5, 2nd Floor
1	Are pharmacists medicine specialists or expert generalists? R. Elvey, J. Hall and K. Hassell
2	A qualitative study evaluating perceptions of hospital pharmacists towards their role in Pakistan’s health care system. S. Azhar, M.A. Hassali and M.I.M. Ibrahim
3	What the Scottish general public think about nonmedical prescribing. K. MacLure, D.C. Stewart, H.L. Diack, C.M. Bond, D.J.
2C	PATIENT INFORMATION - CHAIR: JANE SUTTON - Lecture Theatre 2, 1st Floor
1	Does expert writing and information design improve understanding of a clinical trial participant information sheet? An RCT. P. Knapp, D.K. Raynor, J. Silcock and B. Parkinson
2	A survey of pharmacy users’ understanding of BNF cautionary labels. A.J. Mackridge and A. Abdulla
3	An evaluation of medication information provision to mental health patients. R. Deslandes, L. Pandeli and P.N. Deslandes

4.45pm Finish  
7.00 pm    Conference dinner at the Museum of Science and Industry (MOSI)

DAY 2:  Tuesday 13th April 2010

9.30    Key Note Plenary Presentation 3
“What 5 words best characterise Pharmacy Practice Research?” Professor Peter Noyce
Download Powerpoint presentation (464KB)

Of course, we would probably like them to include vital, visionary, original, robust and sustainable, but what 5 words most accurately describe your own research contribution? Essentially this presentation will explore the nature and landscape of pharmacy practice research, its purpose and its achievements. Which are the disciplines that support and inform the subject and who are our most important collaborators?

It is important to understand how pharmacy practise research contributes. Does it produce - directly or indirectly- patient benefit, increased efficiency of health systems or pharmaceutical operations, or improvements for the pharmaceutical workforce? The impact of research and its measurement is of increasing importance to university departments. What part do impact factors, citation rates and H-indices play in selecting research topics, and how is a shared understanding developed of the impact of pharmacy practice research on policy, practice or education? To be sustainable, pharmacy practice research needs to be resourced. This is not simply a matter of directly funding research projects, but also importantly developing and maintaining a pharmacy practice R&D workforce and infrastructure of adequate capacity and diversity.

What 5 words most accurately characterise pharmacy practice research will largely determine the continuation and level of its resourcing!

Peter Noyce is Professor of Pharmacy Practice, at the University of Manchester, Professional advisor to the Department of Health Professional Regulation and Leadership Oversight Group (PRLOG) and Carter Review of Pharmacy Regulation and Leadership. Peter was also a member of the RAE 2008 pharmacy panel.

10.30    Oral papers: parallel sessions 3

3A	EDUCATION - CHAIR: ANGELA MACADAM - Lecture Theatre 5, 2nd Floor
1	Investigating postgraduate pharmacy students’ approaches to learning in the School of Pharmacy, University of London, UK E. Al-Saeed and A. Safdar
2	Determining which British pharmacy students register to practise S.C. Willis, E.M. Seston and K. Hassell
3	A novel visually-displayed test for assessing numerical skills in pharmacy and nursing students G. Hitch, D. West, R. Jee, R. Foulsham and B. Pearce
4	Learning professionalism in the MPharm: what role does ‘organisational philosophy’ play? E.I. Schafheutle, K. Hassell, D.M. Ashcroft, J. Hall and S. Harrison
3B	PATIENT SAFETY - CHAIR: PAUL BISSELL -Lecture Theatre 2, 1st Floor
1	Medication discrepancies and errors post-discharge from hospital: a pilot evaluation D.P. Alldred, D.R. Petty, C. Standage, A.G. Zermansky, D.K. Raynor and B. Strickland-Hodge
2	Measuring patients’ risk of hospital readmission using the PARR++ tool as a clinical quality indicator F. Darwish Elhajji, M.G. Scott and J.C. McElnay
3	Impact of a new electronic discharge system on the prevalence of prescribing errors I. Riaz and S.D. Williams
4	The impact of professional culture on prescribing safety P.J. Lewis, D.A. Ashcroft, T. Dornan, D. Taylor, V. Wass and M.P. Tully
3C	NEW PHARMACY SERVICES – CHAIR: PETER NOYCE
1	Pharmacist-led management of chronic pain in primary care: patient expectations, attitudes and concerns H. Bruhn, M. Watson, A. Blyth, C.M. Bond and on behalf of Pharmacy-Led Management of Chronic Pain Study Team
2	Pharmacist-led medication therapy adherence clinic: exploring views of health care professionals S. Gnanasan, K.T. Wong, S. Mohd Ali, K.N. Ting and C. Anderson
3	Pharmacist prescribing in clozapine clinics J. Sutton, D.A. Taylor and H.E. Dawson
4	Feedback on pharmacy practice performance: exploring opportunities with the electronic minor ailment service in Scotland V. Paudyal, D. Hansford, I.T.S. Cunningham and D. Stewart

12.15pm to 1.00pm    Attended poster session and Coffee – Common Room, 1st Floor

	POSTERS - JUDGING BY DAVID WRIGHT & MARY TULLY - Common Room, 1st Floor
1	Student evaluation of an enhanced clinical placement programme in undergraduate pharmacy education C. Parsons, R. O’Hare, J.V. Green and M.P. McCartan
2	Are women heeding advice when it comes to what medication is safe to take during pregnancy? M.J. Twigg, L. Holst, D.J. Wright, J. Desborough and Michael Twigg
3	An investigation of the views of community pharmacists’ on their role as a public health practitioner J. Waterfield and N. Mohammed
4	What factors influence a pharmacist’s decision whether or not to supply or sell medicines to children under the age of 16 A. MacAdam and O. Marfo-Mensah
5	What makes a good lecturer? Mpharm students’ views M.L. Hughes, T. Lo, S.A. Coulman, R.E. Deslandes, C. Kell and D.N. John
6	Failure mode effect analysis (FMEA): What do hospital staff in the United Kingdom think of it? N.A. Shebl, B. Dean Franklin and N. Barber
7	A comparison of generic and originator brand drug prices between the Hashemite Kingdom of Jordan and the United Kingdom F. El-Dahiyat, C. McKee and R. Kayyali
8	Why don’t patients with metabolic syndrome achieve recommended blood pressure targets? A pilot study in the United Arab Emirates N. Alozaibi, C. Anderson and M. Boyd
9	Are there geographical variations in uptake of the Scottish Minor Ailments Scheme? A.C. Wagner, P.R. Noyce and D.A. Ashcroft
10	A retrospective audit of medicines use review forms M. Van den Berg and P. Donyai
11	Exploring reasons for spontaneous report of adverse drug reactions by doctors and community pharmacists S. Ferreira and A. Cavaco
12	NHS health checks: The views of community pharmacists and support staff V. Crabtree, J. Hall and M. Gandecha
13	Are pharmacists in Wales recording CPD? S.A. Coulman, W.H. Chong and D.N. John
14	Improving pharmacy students’ self-confidence in pharmaceutical calculations: A longitudinal study D.N. John, S.A. Coulman, S. Shah
15	Does cash payment influence a GP’s decision to prescribe antibiotics? M. Murphy, C.P. Bradley and S. Byrne
16	Facilitators and barriers to pharmacist prescribing: Exploring the association of pharmacy practice setting M.L.P. Dapar, D.J. Mc Caig, I.T.S. Cunningham, L. Diack and D.C. Stewart
17	Antimicrobial consumption in Northern Ireland nursing homes P. McClean, C. Hughes, M. Tunney, D. Gilpin and C. Parsons
18	Conducting a realist review of a complex concept in the pharmacy practice literature: methodological issues S. Jacobs, D. Ashcroft and K. Hassell

1.00pm    Lunch – Common Room, 1st Floor

1.45 pm    Oral papers: parallel sessions 4

4A	COMMUNITY PHARMACY - CHAIR: KAREN HASSELL - Lecture Theatre 2, 1st Floor
1	Exploring ‘ad hoc’ medicines use reviews: methodological and ethical considerations A. Latif, H. Boardman and K. Pollock /td>
2	Can community pharmacy workloads be quantified? W. Gidman and N. Oppon-agyapomaa
3	What is the new medicines use review ‘patient survey’ attempting to capture in the context of existing patient satisfaction with pharmacy questionnaires and a new conceptual framework? M. Van den Berg and P. Donyai
4	What are the key features of the community pharmacy work system? D.L. Phipps and D.M. Ashcroft
4B	MENTAL HEALTH - CHAIR: MARY TULLY TULLY – Lecture Theatre 4, 2nd Floor
1	Enhanced pharmacy services for patients on methadone maintenance therapy: attitudes and expectations of pharmacists M. Jaffray, C. Matheson, C.M. Bond, A.J. Lee, A. Johnstone, B. Davidson and L. Skea
2	‘It’s not my job. I’m the patient not the doctor’: patient perspectives of medicines management in the treatment of schizophrenia D. Stewart, G.B. Anthony and R. Chesson
3	Prevalence of pain in community-dwelling dementia patients in Northern Ireland H. Barry, C. Hughes, C. Parsons and P. Passmore
4	Medication issues for people with early dementia D.A. Taylor and M.C. Weiss
4C	MEDICATION USE - CHAIR: ELLEN SCHAFHEUTLE - Lecture Theatre 5, 2nd Floor
1	Post study analysis of an Internet-based, direct-to-patient expert system for the management of patient self-testing of oral anticoagulant therapy F. Ryan, S. O’Shea and S. Byrne
2	Side effect perception and adherence to fertility drugs during IVF treatment S. Smith and S. Williams
3	Optimisation of secondary prevention of stroke: qualitative study of patients’ beliefs, concerns and difficulties with their medicines C. Souter, A. Kinnear, M. Kinnear and G. Mead
4	Patients and carers’ perspectives on medicines use and supply in an integrated community care pathway service: a qualitative study S. White and J. Carlisle

3.30 pm    Conference summary, handover and announcement of prizes – Lecture Theatre 2, 1st Floor

3.45   Finish and Coffee – Common Room, 1st Floor